Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 17.88 -2.77%

Годовой отчет за 2024 год
добавлен 04.03.2025

report update icon

Rigel Pharmaceuticals Мультипликаторы 2011-2025 | RIGL

Мультипликаторы по годам Rigel Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

22.5 -1.0 -0.4 -24.4 -20.7 -5.9 -4.9 -6.5 -2.8 -4.7 -2.0 -3.1 -4.8 -7.2

P/S

2.2 0.2 0.2 2.9 5.7 6.6 7.8 112.4 9.6 8.4 22.0 38.5 212.9 129.5

EPS

1.0 -1.4 -3.4 -0.1 -0.2 -0.4 -0.4 -0.6 -0.7 -0.6 -1.0 -1.0 -1.3 -1.4

EV (Enterprise Value)

497 млн 139 млн 149 млн 555 млн 660 млн 463 млн 301 млн 484 млн 202 млн 240 млн 192 млн 272 млн 467 млн 617 млн

EBITDA per Share

1.5 -1.11 -3.2 -0.07 -0.17 -0.409 -0.449 -0.627 -0.668 -0.569 -1.01 -0.976 -1.29 -1.33

EV/EBITDA

-28.4 -21.4 -5.5 -3.8 -5.9 -2.8 -4.0 -1.9 -3.0 -4.6 -7.1

PEG

0.03 -0.0 -0.0 0.76 1.22 -0.64 -0.17 -0.43 0.11 -0.11 1.02 -0.14 -1.65 0.02

P/B

119.5 -0.9 -1.9 14.4 18.1 7.3 3.2 5.0 3.6 2.7 1.4 1.3 1.7 2.6

P/CF

12.5 -4.5 -0.3 74.3 -11.8 -9.1 -5.8 -6.5 -2.6 -10.2 -2.6 -3.2 -5.4 -8.6

ROE %

531.78 87.60 430.18 -58.98 -87.42 -124.30 -64.14 -77.49 -125.79 -56.32 -70.89 -42.75 -34.19 -36.41

ROA %

10.66 -21.40 -43.62 -10.71 -26.95 -45.33 -50.67 -65.48 -88.59 -39.06 -58.98 -39.38 -31.88 -33.44

ROCE %

735.77 71.54 407.98 -41.14 -85.15 -77.32 -65.26 -79.00 -115.17 -52.83 -65.13 -40.69 -33.37 -35.17

Current Ratio

1.0 0.8 0.9 1.2 1.4 2.0 4.9 6.4 3.4 3.8 10.7 21.4 24.8 21.7

DSO

73.5 110.7 84.7 38.5 43.8 62.2 33.4 - - 2.6 254.4 293.5 - -

DIO

112.8 375.8 1641.8 1390.9 610.1 545.5 1137.0 - - - - - - -

DPO

102.6 761.1 2744.6 1264.2 1602.5 1672.7 8127.9 - - - - - - -

Операционный цикл

186.2 486.4 1726.5 1429.4 653.9 607.7 1170.4 - - - - - - -

Финансовый цикл

83.7 -274.6 -1018.1 165.2 -948.6 -1065.0 -6957.5 - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.71 -0.06 -0.05 -0.33 -0.38 -0.08 - -0.11 -0.08 -0.16 - -0.12 -0.08 0.23 -0.11 -0.08 -0.1 0.13 -0.1 -0.07 -0.12 -0.11 0.02 -0.14 -0.16 -0.17 -0.18 -0.14 -0.16 -0.13 -0.16 -0.24 -0.15 -0.19 -0.14 -0.08 -0.16 -0.21 -0.25 -0.24 -0.29 -0.25 -0.19 -0.27 -0.26 -0.29 -0.3 -0.36 -0.35 -0.32 -0.36 -0.25 -0.37 -0.4

EBITDA per Share

0.83 0.06 -0.04 -0.24 -0.29 -0.07 - -0.1 -0.08 -0.15 - -0.11 -0.08 0.25 - -0.08 -0.1 0.13 - -0.07 -0.13 -0.11 - -0.14 -0.16 -0.17 - -0.14 -0.16 -0.14 - -0.23 -0.14 -0.19 - -0.06 -0.15 -0.2 - -0.22 -0.28 -0.25 - -0.25 -0.25 -0.29 - -0.33 -0.33 -0.32 - -0.23 -0.35 -0.39

ROE %

-37.50 70.84 123.20 193.14 271.24 614.70 59.19 17.01 -121.16 -508.38 -12.03 -68.56 -68.04 -36.97 -24.98 -0.41 -51.09 -132.86 -228.00 -193.10 -167.84 -142.30 -131.79 -160.43 -145.14 -133.92 -126.95 -129.57 -175.24 -197.33 -213.85 -199.41 -109.25 -68.15 -56.32 -59.80 -68.83 -73.40 -70.89 -61.62 -56.73 -47.86 -42.75 -43.46 -40.83 -38.45 -34.19 -36.30 -35.09 -35.62 -36.41 -7.59 -9.09 -8.80

ROA %

-3.35 -17.89 -28.04 -37.99 -49.52 -62.29 -53.29 -64.52 -40.88 -47.73 0.20 -17.23 -18.84 -8.66 -7.70 -1.93 -22.76 -51.97 -83.14 -69.17 -88.48 -98.49 -104.10 -128.14 -118.91 -111.94 -107.27 -105.50 -130.38 -141.11 -150.61 -140.29 -76.72 -47.61 -39.06 -43.88 -52.41 -58.32 -58.98 -51.99 -48.94 -42.54 -39.38 -40.14 -37.81 -35.72 -31.88 -33.69 -32.46 -32.83 -33.44 -6.97 -8.35 -8.08

ROCE %

-61.51 53.26 107.21 178.00 256.76 590.63 59.08 19.24 -113.37 -485.13 -5.66 -46.16 -46.83 -78.79 -29.82 -52.19 -34.05 -22.59 -96.17 -118.35 -118.16 -102.27 -68.45 -86.19 -81.76 -77.21 -53.06 -94.38 -117.96 -123.55 -98.05 -105.47 -71.57 -62.06 -42.67 -59.08 -68.07 -72.62 -53.71 -65.20 -60.29 -51.43 -34.83 -43.67 -41.02 -38.64 -25.51 -33.15 -31.95 -32.47 -25.60 -7.64 -9.13 -8.83

Current Ratio

0.9 0.8 0.8 0.8 0.8 0.8 0.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

49.1 69.9 78.9 72.0 85.2 122.0 - 31.6 23.3 83.7 - 68.5 277.2 89.1 79.0 79.3 91.0 21.3 59.9 44.2 88.7 51.3 9.8 76.5 208.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

73.0 237.9 285.9 607.9 927.7 943.1 - 1298.7 297.9 5045.1 - 4190.2 4873.7 1239.5 - 1067.6 535.7 880.7 - 398.6 397.3 958.5 - 1182.3 2719.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

56.5 250.4 389.2 476.4 489.6 1345.1 - 496.6 203.2 3170.8 - 1460.3 2399.4 1270.9 - 2416.2 1212.4 2313.3 - 1222.2 1218.2 4495.6 - 8451.9 19439.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

122.1 307.8 364.8 679.8 1012.9 1065.0 - 1330.3 321.2 5128.9 - 4258.8 5150.9 1328.6 79.0 1146.9 626.7 902.0 59.9 442.8 485.9 1009.8 9.8 1258.8 2927.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

65.5 57.4 -24.4 203.5 523.3 -280.0 - 833.7 118.0 1958.1 - 2798.5 2751.5 57.7 79.0 -1269.3 -585.7 -1411.3 59.9 -779.4 -732.3 -3485.7 9.8 -7193.1 -16511.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD